Our Members

Located in:
Zurich

Company:
Daiichi Sankyo

Daiichi Sankyo is a global healthcare leader dedicated to delivering innovative therapies to patients worldwide. Founded in Japan and headquartered in Tokyo, the company builds on a 125-year legacy of scientific innovation, advancing medical care with cutting-edge treatments for oncology and cardiovascular diseases—two leading causes of death globally.

With a global workforce of 19,000, the company has grown significantly in recent years, employing over 3,000 people across its operations in Europe and Canada. Since 1998, the company’s presence in Switzerland has mirrored its global strategy, driving continued growth and success.

The Swiss headquarters in Zurich oversees all business and corporate functions, managed by locally based employees. With a long-term commitment to the country, the company offers multiple products on the market and has others in late-stage clinical development, including in Switzerland.

With a focus on talent development, strategic partnerships, and patient-centered care, Daiichi Sankyo Switzerland is dedicated to making a meaningful and lasting impact on Swiss healthcare and patient wellbeing.

More information at: DE | Daiichi Sankyo

Located in:
Cham (ZG)

Company:
AbbVie

AbbVie is a global, research-based biopharmaceuti­cal company focused on discovering and developing innovative therapies that treat some of the world‘s most serious and complex diseases. AbbVie’s goal is to improve people‘s lives. We focus on the following therapeutic areas: immunology, oncology, neurosci­ence, ophthalmology, virology and gastroenterology.

Headquartered in Chicago, USA, AbbVie employs approximately 50,000 people worldwide. Around 57 million patients in more than 175 countries benefit from AbbVie medicines every year. In Switzerland, 250 employees work for AbbVie. In 2024, AbbVie Switzerland was named one of the best employers in the medium-sized company category by Great Place to Work^® Switzerland for the 10th time in a row.

More information at: AbbVie | Pharmaceutical Research & Development

Located in:
Schaffhausen

Company:
AbbVie

AbbVie is a global, research-based biopharmaceuti­cal company focused on discovering and developing innovative therapies that treat some of the world‘s most serious and complex diseases. AbbVie’s goal is to improve people‘s lives. We focus on the following therapeutic areas: immunology, oncology, neurosci­ence, ophthalmology, virology and gastroenterology.

Headquartered in Chicago, USA, AbbVie employs approximately 50,000 people worldwide. Around 57 million patients in more than 175 countries benefit from AbbVie medicines every year. In Switzerland, 250 employees work for AbbVie. In 2024, AbbVie Switzerland was named one of the best employers in the medium-sized company category by Great Place to Work^® Switzerland for the 10th time in a row.

More information at: AbbVie | Pharmaceutical Research & Development

Located in:
Rotkreuz

Company:
Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative medicines to help millions of patients.

In Switzerland, Amgen established a regional hub in 1989, followed by the Swiss affiliate in 2002.

Amgen helped establish the biotechnology industry more than 40 years ago and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today.

Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and we are also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

More information at: Amgen

Located in:
Baar

Company:
AstraZeneca

AstraZeneca in Switzerland

AstraZeneca is a global, science-led biopharmaceutical company that has been present in Switzerland for nearly 50 years, ranking among the country’s top ten revenue-generating pharmaceutical firms. AstraZeneca focuses on the discovery, development, and commercialisation of prescription medicines in the areas of Oncology, Cardiovascular, Renal and Metabolism, Respiratory and Immunology, and Rare Diseases. Over 285 employees in Switzerland are committed to providing patients with life-changing medicines and making a positive impact on the healthcare system, society, and the planet. Currently, over 230,000 people are treated with a drug from AstraZeneca in Switzerland. By 2026, the company expects the approval of over 35 new therapies. AstraZeneca has pledged to an inclusive work environment based on respect and acceptance. The company was thus recognised as a «Great Place to Work» for the sixth consecutive time in 2024 and carries the «Swiss LGBTI label». AstraZeneca aims to be CO2-negative by 2030.

More information at: AstraZeneca Switzerland

Located in:
Basel

Company:
Bayer

Bayer is a Life Science company with a more than 160-year history. Our approximately 88,000 employees are passionately committed to people’s health care and nutrition all over the world and push ahead with research, development and innovation in these areas. Contributing to sustainable development is a core element of Bayer’s strategy and values. Guided by our vision “Health for all, hunger for none”, we promote inclusive growth and responsible use of resources. Entirely in line with our corporate purpose “Science for a better life”, every single day we work on developing and providing high-quality products which help people to improve their lives.

With our innovative products, we at Bayer Pharma seek to achieve therapeutic benefit for patients, while at the same time satisfying the growing requirements of physicians and health insurers. In Switzerland, Bayer Pharma focuses on the following therapeutic areas: eye diseases, women’s health, cardiovascular diseases, cancers, men’s health and neurology.

Bayer employs approximately 1,360 people at its sites in Zurich, Basel and Muttenz.

Further information on: www.bayer.ch

Located in:
Zurich

Company:
Bayer

Bayer is a Life Science company with a more than 160-year history. Our approximately 88,000 employees are passionately committed to people’s health care and nutrition all over the world and push ahead with research, development and innovation in these areas. Contributing to sustainable development is a core element of Bayer’s strategy and values. Guided by our vision “Health for all, hunger for none”, we promote inclusive growth and responsible use of resources. Entirely in line with our corporate purpose “Science for a better life”, every single day we work on developing and providing high-quality products which help people to improve their lives.

With our innovative products, we at Bayer Pharma seek to achieve therapeutic benefit for patients, while at the same time satisfying the growing requirements of physicians and health insurers. In Switzerland, Bayer Pharma focuses on the following therapeutic areas: eye diseases, women’s health, cardiovascular diseases, cancers, men’s health and neurology.

Bayer employs approximately 1,360 people at its sites in Zurich, Basel and Muttenz.

Further information on: www.bayer.ch

Located in:
Baar

Company:
Biogen

Founded in Geneva in 1978, Biogen is a leading global biotechnology company that has delivered numerous groundbreaking innovations, including a broad portfolio of medicines for the treatment of multiple sclerosis as well as the first approved treatments for spinal muscular atrophy and Friedreich ataxia. The company is committed to the research and development of innovative therapies for people living with serious and complex diseases, particularly in the areas of neurology, neuropsychiatry, immunology, and rare diseases.

Since 2004, Biogen has been managing its operations from its international headquarters in Baar. In Switzerland, Biogen is also present with a state-of-the-art manufacturing facility in Luterbach, which enables the large-scale production of biopharmaceuticals.

More information at: Home (biogen.ch)

Located in:
Luterbach

Company:
Biogen

Founded in Geneva in 1978, Biogen is a leading global biotechnology company that has delivered numerous groundbreaking innovations, including a broad portfolio of medicines for the treatment of multiple sclerosis as well as the first approved treatments for spinal muscular atrophy and Friedreich ataxia. The company is committed to the research and development of innovative therapies for people living with serious and complex diseases, particularly in the areas of neurology, neuropsychiatry, immunology, and rare diseases.

Since 2004, Biogen has been managing its operations from its international headquarters in Baar. In Switzerland, Biogen is also present with a state-of-the-art manufacturing facility in Luterbach, which enables the large-scale production of biopharmaceuticals.

More information at: Home (biogen.ch)

Located in:
Boudry

Company:
Bristol-Myers Squibb (BMS)

Bristol Myers Squibb is a leading global biopharmaceutical company dedicated to discovering, developing and delivering innovative medicines. The company helps millions of people worldwide in therapeutic areas such as oncology, haematology, immunology and neuroscience, as well as cardiovascular disease. In Switzerland, BMS employs more than 1,100 people from 56 nations at two sites. Boudry is home to a significant part of the global R&D organisation as well as medical, commercial and corporate functions. It also hosts a state-of-the-art centre for the manufacturing and testing of small-molecule medicines, which supplies innovative medicines around the world. The new Launch Operations facility for new product launches supports a significant part of the future BMS pipeline. The Swiss headquarters is located in Steinhausen.

More information at: Bristol Myers Squibb

Located in:
Steinhausen

Company:
Bristol-Myers Squibb (BMS)

Bristol Myers Squibb is a leading global biopharmaceutical company dedicated to discovering, developing and delivering innovative medicines. The company helps millions of people worldwide in therapeutic areas such as oncology, haematology, immunology and neuroscience, as well as cardiovascular disease. Due to the importance of the location, Bristol Myers Squibb is involved in international research. In Switzerland, BMS employs more than 1,100 people from 56 nations at two sites: Boudry, a global centre for the manufacture of oral dosage forms and for worldwide drug development, and Steinhausen, the Swiss headquarters.

More information at: Bristol Myers Squibb

Located in:
Basel

Company:
Boehringer Ingelheim

Boehringer Ingelheim works on breakthrough thera­pies that improve the lives of people and animals. Since its foundation in 1885, Boehringer Ingelheim has been family-owned and pursues a long-term per­spective. Around 52,000 employees serve more than 130 markets worldwide in three business areas: Hu­man Pharmaceuticals, Animal Health and Biophar­maceutical Contract Manufacturing. In Switzerland, Boehringer Ingelheim employs around 100 people in Human Pharmaceuticals and Animal Health. The fo­cus is on diseases for which there is yet no satisfacto­ry treatment option. In Human Pharmaceuticals, the main indications are cardiometabolic diseases, diabe­tes, respiratory diseases, oncology, diseases of the central nervous system and immunology. In Animal Health, Boehringer Ingelheim is a world leader in pre­vention through vaccines and antiparasitics.

More information at: Homepage | boehringer-ingelheim.ch

Located in:
Geneva

Company:
Boehringer Ingelheim (AMAL Therapeutics)

Boehringer Ingelheim works on breakthrough thera­pies that improve the lives of people and animals. Since its foundation in 1885, Boehringer Ingelheim has been family-owned and pursues a long-term per­spective. Around 52,000 employees serve more than 130 markets worldwide in three business areas: Hu­man Pharmaceuticals, Animal Health and Biophar­maceutical Contract Manufacturing. In Switzerland, Boehringer Ingelheim employs around 100 people in Human Pharmaceuticals and Animal Health. The fo­cus is on diseases for which there is yet no satisfacto­ry treatment option. In Human Pharmaceuticals, the main indications are cardiometabolic diseases, diabe­tes, respiratory diseases, oncology, diseases of the central nervous system and immunology. In Animal Health, Boehringer Ingelheim is a world leader in pre­vention through vaccines and antiparasitics.

More information at: Homepage | boehringer-ingelheim.ch

Located in:
Vernier

Company:
Eli Lilly and Company

Eli Lilly and Company, a global biopharmaceutical company founded in Indianapolis (USA) in 1876, develops medicines for cardiometabolic, neurodegenerative, oncological and immunological diseases.

Eli Lilly (Suisse) SA has been present in Geneva since 1959. Together with its subsidiary Eli Lilly Export SA, it employs around 200 people and is responsible for marketing medicines in Switzerland and for distribution to small and mid-sized markets worldwide.

Lilly is a member of scienceindustries, Interpharma, GRIP Pharma, FER, GEM, CCIG and the Swiss American Chamber of Commerce, and works with Swiss companies such as AC Immune (Lausanne), HAYA Therapeutics (Epalinges) and KeyBioscience (Lugano).

More information at: Home | Lilly Schweiz and Accueil | Lilly Suisse

Located in:
Schlieren

Company:
Eli Lilly and Company

More information at: Home | Lilly Schweiz and Accueil | Lilly Suisse

Located in:
Zug

Company:
Gilead

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

More information at: Switzerland | Gilead

Located in:
Baar

Company:
GlaxoSmithKline (GSK)

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.

We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

GSK has been operating in Switzerland since 2001 and currently employs around 260 people at its site in Baar in the canton of Zug. Of these, 140 work in the local organization and around 120 in the global hub, focusing on the therapeutic area of oncology.

More information at: Switzerland | GSK

Located in:
Allschwil

Company:
The Janssen Pharmaceutical Companies of Johnson & Johnson

The Janssen Pharmaceutical Companies of Johnson & Johnson is the pharmaceutical division of the Johnson & Johnson family of companies and is one of the lea­ding research-based pharmaceutical companies with around 40,000 employees worldwide and a presence in over 150 countries. The sales organization Janssen Switzerland (Jans­sen-Cilag AG) and employees in the areas of supply chain and logistics are based at the Swiss headquar­ters in Zug. In Switzerland, Janssen has three other entities with over 2,500 emp­loyees – the production site in Schaffhausen (Janssen Schaffhausen), Janssen Vaccines AG in Bern and the site “Campus Basel” in Allschwil (BL), a global research and development center in the field of pulmonary hypertension (formerly Actelion). The Janssen Pharmaceutical Companies of Johnson & Johnson have been developing innovative therapies for over five decades and focuses its research on six therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuro­science, oncology and pulmonary hypertension (high blood pressure in the pulmonary circulation).

More information at: Johnson & Johnson Homepage (jnj.ch)

Located in:
Zug

Company:
The Janssen Pharmaceutical Companies of Johnson & Johnson

The Janssen Pharmaceutical Companies of Johnson & Johnson is the pharmaceutical division of the Johnson & Johnson family of companies and is one of the lea­ding research-based pharmaceutical companies with around 40,000 employees worldwide and a presence in over 150 countries. The sales organization Janssen Switzerland (Jans­sen-Cilag AG) and employees in the areas of supply chain and logistics are based at the Swiss headquar­ters in Zug. In Switzerland, Janssen has three other entities with over 2,500 emp­loyees – the production site in Schaffhausen (Janssen Schaffhausen), Janssen Vaccines AG in Bern and the site “Campus Basel” in Allschwil (BL), a global research and development center in the field of pulmonary hypertension (formerly Actelion). The Janssen Pharmaceutical Companies of Johnson & Johnson have been developing innovative therapies for over five decades and focuses its research on six therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuro­science, oncology and pulmonary hypertension (high blood pressure in the pulmonary circulation).

More information at: Johnson & Johnson Homepage (jnj.ch)

Located in:
Schaffhausen

Company:
The Janssen Pharmaceutical Companies of Johnson & Johnson

The Janssen Pharmaceutical Companies of Johnson & Johnson is the pharmaceutical division of the Johnson & Johnson family of companies and is one of the lea­ding research-based pharmaceutical companies with around 40,000 employees worldwide and a presence in over 150 countries. The sales organization Janssen Switzerland (Jans­sen-Cilag AG) and employees in the areas of supply chain and logistics are based at the Swiss headquar­ters in Zug. In Switzerland, Janssen has three other entities with over 2,500 emp­loyees – the production site in Schaffhausen (Janssen Schaffhausen), Janssen Vaccines AG in Bern and the site “Campus Basel”  in Allschwil (BL), a global research and development center in the field of pulmonary hypertension (formerly Actelion). The Janssen Pharmaceutical Companies of Johnson & Johnson have been developing innovative therapies for over five decades and focuses its research on six therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuro­science, oncology and pulmonary hypertension (high blood pressure in the pulmonary circulation).

More information at: Johnson & Johnson Homepage (jnj.ch)

Located in:
Opfikon

Company:
Lundbeck

Lundbeck (Schweiz) AG is the subsidiary of the Da­nish pharmaceutical company of the same name and has been in existence since 1948. Since 2016, the Swiss subsidiary has been located in the Zurich air­port area. Today, 70% of the Lundbeck company is owned by the Lundbeck Foundation, which was es­tablished in 1954. The Lundbeck Foundation awards around CHF 70 million in independent research fun­ding each year and also awards the world‘s largest Brain Prize. Each year, the Lundbeck Foundation awards approximately 1.3 million Swiss francs to one or more brain researchers who have made a ground­breaking contribution to neuroscience. The H. Lund­beck A /S company invests in research into new drugs to treat diseases of the central nervous system, with a focus on migraine, depression and schizophrenia. In addition to developing new and increasingly better drug therapies, we also advocate for those affected and their families and fight for social acceptance of people with brain diseases.

More information at: lundbeck.com

Located in:
Aubonne

Company:
Merck

Merck in Switzerland

At Merck, our pioneering spirit drives us to develop innovations to improve, extend, or even create life. As a globally leading science and technology company, we invest significant resources in research and development in the fields of Life Science, Healthcare, and Electronics. For 95 years, Merck has employed around 2,600 employees across nine locations in Switzerland to create responsible progress together.

Our therapeutic areas include oncology, fertility & endocrinology, neurology & immunology, as well as general medicine. As part of our initiatives in global health, we actively strive to eliminate schistosomiasis.

Diversity and inclusion are at the heart of our identity. We recognize that our future success relies on our ability to create an environment that promotes equal opportunities and inclusion. Our commitment to these values reflects our vision for a better future.

More information at: Merck – The Vibrant Science & Technology Company (merckgroup.com)

Located in:
Schaffhausen

Company:
Merck

Merck in Switzerland

At Merck, our pioneering spirit drives us to develop innovations to improve, extend, or even create life. As a globally leading science and technology company, we invest significant resources in research and development in the fields of Life Science, Healthcare, and Electronics. For 95 years, Merck has employed around 2,600 employees across nine locations in Switzerland to create responsible progress together.

Our therapeutic areas include oncology, fertility & endocrinology, neurology & immunology, as well as general medicine. As part of our initiatives in global health, we actively strive to eliminate schistosomiasis.

Diversity and inclusion are at the heart of our identity. We recognize that our future success relies on our ability to create an environment that promotes equal opportunities and inclusion. Our commitment to these values reflects our vision for a better future.

More information at: Merck – The Vibrant Science & Technology Company (merckgroup.com)

Located in:
Altdorf

Company:
Merck

Merck in Switzerland

At Merck, our pioneering spirit drives us to develop innovations to improve, extend, or even create life. As a globally leading science and technology company, we invest significant resources in research and development in the fields of Life Science, Healthcare, and Electronics. For 95 years, Merck has employed around 2,600 employees across nine locations in Switzerland to create responsible progress together.

Our therapeutic areas include oncology, fertility & endocrinology, neurology & immunology, as well as general medicine. As part of our initiatives in global health, we actively strive to eliminate schistosomiasis.

Diversity and inclusion are at the heart of our identity. We recognize that our future success relies on our ability to create an environment that promotes equal opportunities and inclusion. Our commitment to these values reflects our vision for a better future.

More information at: Merck – The Vibrant Science & Technology Company (merckgroup.com)

Located in:
Buchs

Company:
Merck

Merck in Switzerland

At Merck, our pioneering spirit drives us to develop innovations to improve, extend, or even create life. As a globally leading science and technology company, we invest significant resources in research and development in the fields of Life Science, Healthcare, and Electronics. For 95 years, Merck has employed around 2,600 employees across nine locations in Switzerland to create responsible progress together.

Our therapeutic areas include oncology, fertility & endocrinology, neurology & immunology, as well as general medicine. As part of our initiatives in global health, we actively strive to eliminate schistosomiasis.

Diversity and inclusion are at the heart of our identity. We recognize that our future success relies on our ability to create an environment that promotes equal opportunities and inclusion. Our commitment to these values reflects our vision for a better future.

More information at: Merck – The Vibrant Science & Technology Company (merckgroup.com)

Located in:
Corsier-sur-Vevey

Company:
Merck

Merck in Switzerland

At Merck, our pioneering spirit drives us to develop innovations to improve, extend, or even create life. As a globally leading science and technology company, we invest significant resources in research and development in the fields of Life Science, Healthcare, and Electronics. For 95 years, Merck has employed around 2,600 employees across nine locations in Switzerland to create responsible progress together.

Our therapeutic areas include oncology, fertility & endocrinology, neurology & immunology, as well as general medicine. As part of our initiatives in global health, we actively strive to eliminate schistosomiasis.

Diversity and inclusion are at the heart of our identity. We recognize that our future success relies on our ability to create an environment that promotes equal opportunities and inclusion. Our commitment to these values reflects our vision for a better future.

More information at: Merck – The Vibrant Science & Technology Company (merckgroup.com)

Located in:
Eysins

Company:
Merck

Merck in Switzerland

At Merck, our pioneering spirit drives us to develop innovations to improve, extend, or even create life. As a globally leading science and technology company, we invest significant resources in research and development in the fields of Life Science, Healthcare, and Electronics. For 95 years, Merck has employed around 2,600 employees across nine locations in Switzerland to create responsible progress together.

Our therapeutic areas include oncology, fertility & endocrinology, neurology & immunology, as well as general medicine. As part of our initiatives in global health, we actively strive to eliminate schistosomiasis.

Diversity and inclusion are at the heart of our identity. We recognize that our future success relies on our ability to create an environment that promotes equal opportunities and inclusion. Our commitment to these values reflects our vision for a better future.

More information at: Merck – The Vibrant Science & Technology Company (merckgroup.com)

Located in:
Zug

Company:
Merck

Merck in Switzerland

At Merck, our pioneering spirit drives us to develop innovations to improve, extend, or even create life. As a globally leading science and technology company, we invest significant resources in research and development in the fields of Life Science, Healthcare, and Electronics. For 95 years, Merck has employed around 2,600 employees across nine locations in Switzerland to create responsible progress together.

Our therapeutic areas include oncology, fertility & endocrinology, neurology & immunology, as well as general medicine. As part of our initiatives in global health, we actively strive to eliminate schistosomiasis.

Diversity and inclusion are at the heart of our identity. We recognize that our future success relies on our ability to create an environment that promotes equal opportunities and inclusion. Our commitment to these values reflects our vision for a better future.

More information at: Merck – The Vibrant Science & Technology Company (merckgroup.com)

Located in:
Basel

Company:
Moderna

Biotech firm Moderna was established in Cambridge, Massachusetts, USA, in 2010, and has since been working towards building an industry-leading mRNA technology platform. Moderna opened its Swiss subsidiary and EMEA (Europe, Middle East and Africa) headquarters in Basel in September 2020. With the approval of the RNA vaccine against the SARS-CoV-2 virus, Moderna made a key contribution to fighting the pandemic. Moderna’s goal is to meet the expectations associated with mRNA research for a new generation of transformational medicines for patients. Moderna develops mRNA medications for various forms of administration and makes them available to patients around the world. Our work currently focuses on six medical fields: infectious diseases, immuno-oncology, rare diseases, autoimmune diseases, personalized cancer vaccines and cardiovascular diseases.

More information at: Pioneering mRNA technology – Moderna (modernatx.com)

Located in:
Lucerne, Rösslimatt

Company:
MSD (Merck Sharp & Dohme)

More information at: MSD Switzerland – Inventing for life | msd.ch

Located in:
Schachen

Company:
MSD (Merck Sharp & Dohme)

Our site in Schachen plays a key role in the provision of new innovative medicines. More than 400 employees and service providers from nations around the globe work here.

Our focus lies on the production and testing of new biological medicines. Furthermore we provide analytical services for drugs in development within our global organization. From Schachen, we also export new drugs for clinical trials so that the safety and efficacy of the new therapeutics can be determined in worldwide tests. In addition to the activities in the development area, the site also provides services to MSD manufacturing sites. Thus, MSD operates a laboratory in Schachen, where suspected cases of drug counterfeiting are investigated. There are only 3 such laboratories in the world, one in the USA and another in Singapore. We have been supporting the Swiss vocational training system since 1977 by providing young apprentices with training and employment opportunities, and often continuing to employ them after they have completed their apprenticeships.

Werthenstein BioPharma GmbH
Industrie Nord 1
CH-6105 Schachen (Lucerne)

More information at: MSD Switzerland – Inventing for life | msd.ch

Located in:
Zurich

Company:
MSD (Merck Sharp & Dohme)

Since fall 2021, around 250 employees work at our new site at THE CIRCLE at Zurich Airport. They focus on accelerating research, data collection and analysis, and commercialization of our medicines and vaccines. The new office is staffed with teams working in strategic and operational roles in Medical Affairs, Clinical Development, Market Access and Marketing Operations.

MSD Innovation & Development GmbH
The Circle 66
CH-8058 Zurich Airport

More information at: MSD Switzerland – Inventing for life | msd.ch

Located in:
Basel

Company:
Novartis

Novartis is a global company with Swiss roots stretching back over 250 years. As a leading global pharmaceutical company, we harness scientific innovations and digital technologies to develop groundbreaking treatments in areas of significant medical need. Novartis operates in over 120 countries and has its global headquarters in Basel. Around the world, some 77,050 employees work for Novartis, including 9,800 in Switzerland. Novartis has five sites in Switzerland: Basel (Canton of Basel-Stadt), Schweizerhalle (Canton of Basel-Landschaft), Stein (Canton of Aargau), Geneva (Canton of Geneva) and Rotkreuz (Canton of Zug). The Novartis Campus in Basel is one of our most important research locations. Around 7,000 employees work here. Scientists from all over the world research innovative drugs and treatments here.

More information at: Home | Novartis Schweiz

Located in:
Geneva

Company:
Novartis

Site of Advanced Accelerator Applications (AAA), a Novartis company focused on nuclear medicine therapies.

More information at: Home | Novartis Schweiz

Located in:
Rotkreuz

Company:
Novartis Pharma Switzerland

The Rotkreuz business unit is responsible for marketing around 75 prescription medications in Switzerland. Key therapeutic areas include oncology, the cardiovascular system, immunology and neuroscience.

The company employs around 220 internal and field staff in areas such as medical consulting, quality assurance, marketing and sales, logistics, order processing and clinical trial coordination.

More information at: Novartis Pharma Schweiz | Novartis Schweiz

Located in:
Schweizerhalle BL

Company:
Novartis

Schweizerhalle is an important Novartis production site for the manufacture and launch of chemical products. Small-volume, innovative active ingredients and intermediates for various medicines are produced here. The site also has a modern production facility for RNA oligonucleotides.

More information at: Home | Novartis Schweiz

Located in:
Stein

Company:
Novartis

Stein is an important Novartis production site for the manufacture and launch of innovative medicines and treatments. The site is a centre of excellence for sterile and solid dosage forms as well as for personalised cell and gene therapies. Every year, millions of tablets, capsules, syringes, ampoules, pens and personalised medicines are produced here and shipped to around 120 countries worldwide.

More information at: Home | Novartis Schweiz

Located in:
Zurich

Company:
Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes.

We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.

With our “Circular for Zero” environmental strategy, we are pursuing a goal as a sustainable company to achieve zero environmental impact in all our business activities. We are the first pharmaceutical company to be using 100% renewable energy in all our global production facilities since 2020.

Novo Nordisk employs about 61,400 people in 80 countries and markets its products in around 170 countries. The first branch outside Denmark was established in 1930, in Switzerland. Today, there are around 360 employees working at the Zurich Airport site, almost a third of whom work for the Swiss branch.

More information (in German): Novo Nordisk Pharma Ltd

© Flughafen Zürich AG

Located in:
Zurich

Company:
Pfizer

Pfizer has been based in Switzerland since 1959 and makes a key contribution to healthcare provision for the local population. Pfizer sells more than 100 prescription medicines throughout Switzerland.

More information at: Startseite | Pfizer Switzerland

Located in:
Zug

Company:
Pfizer

Pfizer has been based in Switzerland since 1959 and makes a key contribution to healthcare provision for the local population. Pfizer sells more than 100 prescription medicines throughout Switzerland.

More information at: Startseite | Pfizer Switzerland

Located in:
Basel/Kaiseraugst

Company:
Roche

Basel/Kaiseraugst is one of Roche’s largest sites worldwide, with 12,400 employees from more than 106 nations. Basel is also home to the headquarters of the Roche Group. The entire value chain is covered here, from research and development to production and distribution.

In addition to the Executive Board, Basel is also home to all global functions. With its 170 employees, Roche Pharma (Switzerland) Ltd in Basel is responsible for clinical trials, sales, medical affairs as well as registration and quality assurance of Roche’s medicines in Switzerland. Roche is also one of the larger training companies in Switzerland, with 300 apprentices in 15 different professions at the Basel/Kaiseraugst site.

Kaiseraugst is the Roche Group’s global logistics hub, with pharmaceutical production and packaging. From here, Roche ships medicines to patients worldwide.

In addition to pharmaceutical production and packaging, Kaiseraugst is a leading global IT hub and a training and development centre.

Since 2016, Roche has invested around CHF 41 billion in Switzerland. Of this, more than CHF 7 billion went into the expansion and modernisation of its Swiss sites and over CHF 33 billion into research and development. These investments underline Roche’s long-term commitment to Switzerland as a business and research location.

More information at: Roche Switzerland

Located in:
Rotkreuz

Company:
Roche Diagnostics International Ltd

Rotkreuz is the global headquarters of Roche Diagnostics and brings together all central functions and business areas. The entire value chain of the diagnostics business is concentrated here.

Roche Diagnostics International Ltd in Rotkreuz ZG was founded in 1969 and is today a leading global provider of diagnostic system solutions. With around 2,990 employees from 79 nations, the company is the largest private employer in the canton of Zug. Innovative tests and systems for the rapid and reliable diagnosis of diseases are developed here. The company is also the largest manufacturer of fully automated, integrated in vitro diagnostic systems in Switzerland. The site is also home to the EMEA/LATAM sales region as well as the country organisation Roche Diagnostics (Switzerland) Ltd and Roche Diabetes Care. With 176 apprentices in 11 different professions, Rotkreuz is another Roche training site.

More information at: Roche Diagnostics

Located in:
Schlieren

Company:
Roche

Roche Innovation Center Zurich is Roche Pharma Research and Early Development’s (pRED) Center of Excellence for Cancer Immunotherapy. One major focus is the development of engineered antibodies that address unmet clinical needs. Roche Innovation Center Zurich is one of Roche’s antibody engineering powerhouses.

Roche Innovation Center Zurich aims to position itself among the leading companies in the development of new generations of therapeutic antibodies with increased efficacy in clinical conditions with medical need.

90 employees from 20 nations work in Schlieren.

Glycart Biotechnology AG was initially established in September 2000 as a spin-off of the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland. In the summer of 2005, it was acquired by the Roche Group and integrated in Roche Pharma Research and Early Development (pRED).

More information at: Roche Switzerland

Located in:
Rotkreuz

Company:
Sanofi

Sanofi is an innovative global healthcare company with a mission to chase the miracles of science to improve people’s lives. Worldwide, approximately 75,000 employees are committed to transforming medicine. In Switzerland, Sanofi is organized into three business units with approximately 157 employees in Rotkreuz and Vernier: Specialty Care (immunology, oncology, rare diseases, multiple sclerosis), Vaccines and General Medicines (diabetes, cardiovascular, atherothrombosis/thrombosis).

More information at: Sanofi Schweiz

Located in:
Vernier

Company:
Sanofi

Sanofi is an innovative global healthcare company with a mission to chase the miracles of science to improve people’s lives. Worldwide, approximately 75,000 employees are committed to transforming medicine. In Switzerland, Sanofi is organized into three business units with approximately 157 employees in Rotkreuz and Vernier: Specialty Care (immunology, oncology, rare diseases, multiple sclerosis), Vaccines and General Medicines (diabetes, cardiovascular, atherothrombosis/thrombosis).

More information at: Sanofi Schweiz

Located in:
Neuchâtel

Company:
Takeda

With around 700 employees, Takeda Neuchâtel is one of the ten largest employers in the Canton of Neuchâtel and one of Switzerland’s leading biopharmaceutical production sites. The site operates 24/7 and employs a large number of specialists who have trained in biotechnology and its industrial production applications. With more than 20 nationalities represented in its workforce, Takeda Neuchâtel offers an international, diverse and innovative work environment in a company that is rooted in and committed to its local community. Takeda Neuchâtel is certified as a training company by the Swiss State Secretariat for Economic Affairs. We train young people in various fields, including laboratory quality control, logistics, IT and biopharmaceutical production.

More information at: Takeda In der Schweiz

Located in:
Zurich

Company:
Takeda

Founded in Japan in 1781, Takeda is now a leading global, value-driven, research-based biopharmaceutical company. In around 80 countries worldwide, some 50,000 employees are committed to improving patients’ quality of life and working with all healthcare partners.

Takeda entered the Swiss market in 1986 under the name Takeda Pharma AG. Since January 2020, Takeda Switzerland has been located in Glattpark-Opfikon near Zurich, together with numerous international departments and functions. In total, around 1,000 employees are based at this site. The focus of Takeda Switzerland is on the approval and distribution of medicinal products for the Swiss market. A further 700 or so employees at the production site in Neuchâtel manufacture recombinant blood clotting factors for the global market.

More information at: Takeda In der Schweiz

Located in:
Bulle

Company:
UCB

UCB is a global biopharmaceutical company specialising in immunology and neurology. UCB is headquar­tered in Brussels (Belgium) and employs almost 9000 people in over 40 countries, including around 700 qualified employees in Switzerland. Since 1996, UCB has invested more than 600 million Swiss francs in the construction and installation of state-of-the-art industrial facilities at its site in Bulle (canton of Fribourg). The UCB affiliate in Bulle helps to improve the lives of thousands of people around the world suffering from serious diseases. In terms of fairness, it is the first pharmaceutical company in Switzerland to be Equal Salary certified for equal pay between men and women.

More information at: UCB Schweiz

Located in:
EPFL (Lausanne)

Company:
Merck

Merck in Switzerland

At Merck, our pioneering spirit drives us to develop innovations to improve, extend, or even create life. As a globally leading science and technology company, we invest significant resources in research and development in the fields of Life Science, Healthcare, and Electronics. For 95 years, Merck has employed around 2,600 employees across nine locations in Switzerland to create responsible progress together.

Our therapeutic areas include oncology, fertility & endocrinology, neurology & immunology, as well as general medicine. As part of our initiatives in global health, we actively strive to eliminate schistosomiasis.

Diversity and inclusion are at the heart of our identity. We recognize that our future success relies on our ability to create an environment that promotes equal opportunities and inclusion. Our commitment to these values reflects our vision for a better future.

More information at: Merck – The Vibrant Science & Technology Company (merckgroup.com)